Op-ed piece from Dr. Andrew Tatarsky,  president of the

New Post Public Reply Private Reply Replies (0) Message Board
bellsandwhistles
Op-ed piece from Dr. Andrew Tatarsky,  president of the Division of Addiction of the New York State Psychological Association and founder and director of the Center for Optimal Living, an addiction treatment and professional training center in New York City. He has specialized in the field of substance use treatment for over 30 years. He slams addictive and abuse-prone Big Pharma drugs.

Medical marijuana is humane
By Dr. Andrew Tatarsky
Tuesday, January 28, 2014

As a psychologist who has specialized in substance use treatment for over 30 years, I have given a lot of thought to medical marijuana. Over the years, I have seen several patients who have used marijuana medicinally but have suffered — from potential criminal prosecution and the shame, stigma and fear that comes from using an illicit substance. Twenty states and D.C. now permit the use of medical marijuana. New York should join them.

I applaud Gov. Andrew Cuomo's recent acknowledgement of cannabis' medical value for some seriously ill people. However, the 1980 Olivieri Law that he is using, through which medical marijuana would be available through 20 hospitals around the state, has significant restrictions, preventing many patients who need the medicine from receiving it.

The Legislature is currently considering the Compassionate Care Act, which would create one of the best-regulated medical marijuana programs in the country. I urge Cuomo to work with the Legislature to enact this comprehensive legislation this session. Many of my colleagues in the addiction and mental health treatment communities support this bill, as reflected in endorsements by the New York State Psychological Association and its Division on Addiction.

Allowing the seriously ill access to safe and legal medical marijuana under their health care provider's supervision is, fundamentally, an issue of compassion and human rights . The medical value of cannabis is no longer a matter of dispute. The efficacy of cannabis for controlling certain conditions and symptoms is well-established in the scientific literature. And, compared to other prescription medications, like widely used opioid pain relievers, medical cannabis is relatively safe, having no known lethal dose and few side effects.

The Compassionate Care Act will ultimately make the job of drug treatment professionals like me easier. The worst dangers associated with medical marijuana come from forcing patients to seek medical marijuana on the illicit market, with potentially devastating consequences — like untested and possibly contaminated product, lifelong criminal records, and shame and stigma from using an illegal substance.

It's time to acknowledge that our current efforts to prohibit marijuana use, by pushing an abstinence-only message and exaggerating the dangers, have failed. Marijuana use by young people can be a problem and should be discouraged, but denying those with debilitating medical conditions access to medical marijuana is not a winning prevention strategy.

When our young people learn that their drug education is filled with misinformation about marijuana, we lose credibility and damage our ability to teach them accurate information about the real dangers of marijuana and other drugs.

We need honest, reality-based drug prevention and treatment programs to reduce the problematic use of marijuana by children and adults alike.

In fact, another reason I support the Compassionate Care Act is because it would generate and earmark substantial funding for such prevention programs, which have unfortunately been devastated by cuts in recent years.

I am not suggesting that medical marijuana is the right choice for everyone. There are risks associated with using it, just as with any medication. Medical marijuana shouldn't be recommended for use in adolescents, unless there is a compelling medical need, and people with particular mental illnesses, especially schizophrenia, should avoid using it.

There is also the risk, in a small percentage of users, of overuse and addiction; those cases should be referred to mental health and substance use treatment professionals for assessment and treatment. But we can best assess our patients and address these risks by having an open and honest dialogue — something nearly impossible for most health care practitioners in New York right now.

Our responsibility as drug treatment providers is to work with our patients to help them create full, meaningful, and healthy lives.

We have long had to deal with helping clients who use potentially dangerous and addictive medications (i.e., from Big Pharma) to treat illnesses, and we do so because no one should have to suffer needlessly.

Medical marijuana is a fundamental matter of compassion, and bringing it into a safe, regulated and de-stigmatizing system will solve far more problems than does our current system of criminalizing our sickest and most vulnerable citizens.
http://www.timesunion.com/opinion/article/Med...182570.php

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 3

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
India's First Upright Proton Therapy System Unveiled

Updated Category News Views 6

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts

Updated Category News Views 2

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Continue Reading
Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 1

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
Intellectia.AI Transforming Trading with AI Upgrades

Updated Category News Views 2

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Continue Reading
Life Flower Celebrates 16 Years with Dog Adoption Event

Updated Category News Views 3

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

Continue Reading
Tiger Group to Auction Huge Window Manufacturing Plant

Updated Category News Views 5

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Continue Reading
BrightPlan's AI-Powered Growth: Series C Fuel

Updated Category News Views 5

Series C Funding Ignites BrightPlan's Ambitions Ever seen a company that's ready to roll with the punches and come out stronger? That's BrightPlan for you. They're pushing the boundaries again, bagging new capital in this Series C round, steered by the seasoned folks over at ABS Capital Partners. Now, here's the thing: We're talking about a 230% revenue surge over just...

Continue Reading
Illinois' Legal Tangle: Feds Under Fire?

Updated Category News Views 2

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 3

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading

Top 5 Most Recently Viewed Articles

Primax & Qualcomm Edge AI: Reshaping Meetings

Updated Category News Views 7

Enhanced AI Driven Conferencing: Welcome to 2026 Primax Electronics is firing on all cylinders. Those folks are pretty intent on reshaping the digital meeting landscape with their new AI conference solutions, a move that aligns with the rapidly changing nature of business interactions. And let me tell you, there’s more here than meets the eye—for Primax, the shift...

Continue Reading
USD Partners Moves Toward Final Asset Sale with Future Plans

Updated Category News Views 185

USD Partners LP Anticipates Sale of Key Asset USD Partners LP (OTC: USDP) has announced that it is set to complete the sale of its Hardisty Rail Terminal, which stands as its last operational asset. This significant step comes as a requirement imposed by its lending institutions associated with the revolving credit facility. The partnership has carefully navigated a path...

Continue Reading
AUD/USD Faces Uphill Battle as Economic Factors Shift

Updated Category News Views 77

AUD/USD Faces Uphill Battle as Economic Factors Shift The AUD/USD currency pair is presently navigating turbulent waters, trying to inch closer to 0.6681. However, this attempt at recovery presents a tricky scenario as it lingers near a six-week low. The US dollar's ascent, coupled with rising US Treasury yields, is largely fueled by speculations surrounding a favorable...

Continue Reading
Unraveling the Impact of Rare Earth Metals in Industries

Updated Category News Views 146

Understanding the Rare Earth Metals Market The global market for rare earth metals is witnessing a significant transformation, projected to reach an impressive USD 7,386.3 million by 2030. This projection stems from growing demand across various high-tech sectors, including clean energy, electronics, and defense technologies. In 2024, the market was valued at USD 5,139.1...

Continue Reading
Growing Opportunities in the U.S. Drug Screening Market

Updated Category News Views 162

Revolutionizing Drug Testing in the U.S. The U.S. drug screening market has been gaining significant momentum, projected to expand from its current value of USD 2.70 billion to an impressive USD 3.84 billion by 2034. This represents a compound annual growth rate (CAGR) of approximately 3.64%. The rise in market demand can be attributed to various factors, including...

Continue Reading